Back to news

Korro to Participate in Upcoming Investor Conferences

Globe Newswire•19/11/2026•07:00 ET
0

Key Highlights

  • ➤Korro CEO Ram Aiyar will participate in three investor conferences December 1-3, 2026
  • ➤Evercore Healthcare Conference fireside chat scheduled for December 1 in Miami
  • ➤Citi Global Healthcare Conference one-on-one meetings scheduled for December 2 in Miami
  • ➤Piper Sandler Healthcare Conference fireside chat scheduled for December 3 in New York

CAMBRIDGE, Mass., Nov. 19, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company leveraging a novel Oligonucleotide Promoted Editing of RNA (OPERA(®)) platform to develop a new class of genetic medicines for rare and highly prevalent diseases, today announced that Ram Aiyar, Ph.D., Chief Executive Officer and President, will participate in the following investor conferences:

9(th) Annual Evercore Healthcare Conference Format: Fireside chat moderated by Jonathan Miller, Biotech and Pharma Equity Research, Evercore Date: December 1, 2026 Location: Miami, FL Time: 7:55AM ET

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in